Poochanasri, Methavee
Lertsakulbunlue, Sethapong
Kookanok, Chutawat
Rangsin, Ram
Kaewput, Wisit
Mungthin, Mathirut
Samakkarnthai, Parinya
Article History
Received: 23 May 2024
Accepted: 15 March 2025
First Online: 9 May 2025
Declarations
:
: The study was approved by the Institutional Review Board, Royal Thai Army (Approved No. Q004h/67), in accordant with international guidelines including the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use - Good Clinical Practice (ICH-GCP). Due to using secondary data, a waiver of documentation of informed consent was utilized, and the waiver for informed consent was granted by the Institutional Review Board, RTA Medical Department.
: Not applicable.
: The authors declare no competing interests.